Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Explore methods to stay financially stable mid-month, including disciplined review and targeted adjustments that protect your budget.
23,913 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
As AI accelerates,Microsoft's split with OPENAI could reshape strategy and investor returns. Learn what this means fo...
A single platform now powers a large share of global digital infrastructure, triggering merger chatter and forcing in...
As the next market cycle approaches, traders are weighing XRP against Hyperliquid, weighing price action, liquidity, ...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...
As markets shift in 2026, Netflix and Disney face different risk-reward profiles. This analysis weighs dividends, val...
Blockchain tracker Lookonchain flags hype linked to Arthur Hayes as he denies fresh HYPE purchases after a roughly $2...
Lee’s Bitmine moved to grow its ETH treasury with a $41 million purchase, signaling a continued expansion strategy ev...
Bitcoin stabilizes after a volatile week, signaling a potential turn for BTC as investors eye SpaceX's blockbuster IP...
DGRO targets companies with five straight years of dividend growth and a cap on payout ratios, aiming for a rising in...
Goldman Sachs names Marvell Technology and Micron Technology as the linchpins of the next AI deployment cycle, elevat...
As interest rates hover higher, retirees seek dependable income. Philip Morris International stands out as a dividend...